Predicting toxicity caused by high-dose-rate brachytherapy single boost for prostate cancer

PURPOSE: Treating localized prostate cancer (PC) with combination radiotherapy consisting of external beam radiotherapy (EBRT) and high-dose-rate brachytherapy (HDR-BT) has been proven to result in better disease outcome than EBRT only. We aimed to evaluate the incidence of toxicities due to combina...

Descripción completa

Detalles Bibliográficos
Autores principales: Olsén, Johan Staby, Estefan, Dalia, Valachis, Antonios, Jakobsson, Frida, Karlsson, Leif, Johansson, Bengt
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Termedia Publishing House 2022
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8867235/
https://www.ncbi.nlm.nih.gov/pubmed/35233229
http://dx.doi.org/10.5114/jcb.2022.113545

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8867235/
https://www.ncbi.nlm.nih.gov/pubmed/35233229
http://dx.doi.org/10.5114/jcb.2022.113545

Ejemplares similares